Skip to main content
Clinical Trials/CTRI/2024/02/062976
CTRI/2024/02/062976
Not yet recruiting
Phase 2

Clinical study of add on effect of rohitakadi churna along with metformin-sr in the management of prameha (niddm) - Nil

Tilak Ayurved Mahavidyalaya0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: E119- Type 2 diabetes mellitus without complications
Sponsor
Tilak Ayurved Mahavidyalaya
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\)Newly diagnosed diabetic patients of age group in between 40 to 70 yrs
  • 2\)patient of any gender ,religion and socio\-economic status
  • 3\)patients having signs and symptoms of prameha
  • 4\)blood sugar level(fasting\-126 to 160 mg/dl)(post prandial\-160 to 250 mg/dl)
  • 5\)hba1c\-6\.5\-9%

Exclusion Criteria

  • known case of type\-1 diabets mellitus
  • patint on insulin or steroid treatment
  • patint with any other known systemic disorder
  • pregnant women and lactating mothers

Outcomes

Primary Outcomes

Not specified

Similar Trials